Navigation Links
Cardiome And Astellas Announce Regulatory Update
Date:1/21/2008

NASDAQ: CRME TSX: COM

VANCOUVER and DEERFIELD, IL, Jan. 21 /PRNewswire-FirstCall/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) and its co-development partner Astellas Pharma US, Inc. ("Astellas") today announced that they have been informed by the U.S. Food and Drug Administration (FDA) that a decision has not yet been made regarding the New Drug Application (NDA) for KYNAPID(TM) (vernakalant hydrochloride). The FDA did not provide an action letter prior to the PDUFA date of January 19, 2008.

"While we look forward to the FDA reaching a decision, we respect their need for additional time to review the KYNAPID NDA," said William E. Fitzsimmons, PharmD, Senior Vice President, Research & Development at Astellas. "Astellas and Cardiome strongly believe in the therapeutic value of KYNAPID based on clinical trial data and are confident it will be an important therapy in the treatment of atrial fibrillation."

In October 2003, Cardiome granted Astellas Pharma US, Inc. an exclusive license to develop and commercialize KYNAPID in North America. Cardiome has retained all rights to the intravenous formulations outside of Canada, the U.S. and Mexico. The NDA for KYNAPID, based on a five-year clinical development program, was submitted in December 2006. In December 2007, the FDA Cardiovascular and Renal Drugs Advisory Committee voted 6-2 in favour of recommending to the FDA that KYNAPID be approved for the rapid conversion of acute AF to sinus rhythm.

About Cardiome

Cardiome Pharma Corp. is a product-focused cardiovascular drug development company with two late-stage clinical drug programs focused on atrial arrhythmia (intravenous and oral dosing), a Phase 1 program for GED-aPC, an engineered analog of recombinant human activated Protein C, and a pre-clinical program directed at improving cardiovascular function.

Vernakalant (iv) is the intravenous formulation of an investigational drug being evaluated f
'/>"/>

SOURCE Cardiome Pharma Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Cardiome to Hold Investor Update Call
2. Cardiome Updates Guidance
3. Cardiome Initiates Phase 1 Study for GED-aPC
4. Cardiome To Release Third Quarter Results
5. Cardiome to Present at CIBC Conference
6. Cardiome to Present at ThinkEquity Conference
7. Cardiome to Present at Bear Stearns Conference
8. Pharmacyclics Announces Conference Call to Discuss Second Quarter 2008 Financial Results
9. Cardica to Announce Fiscal 2008 Second Quarter Financial Results on Thursday, January 24, 2008
10. Lance Armstrong and 17th U.S. Surgeon General Carmona Announce National Call to Action in the War Against Cancer
11. Bradley Pharmaceuticals Announces Filing of Definitive Proxy Statement for Special Meeting of Stockholders to Approve Merger With Nycomed
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... April 17, 2014U.S. military personnel who served in ... concussive traumatic brain injury (TBI) were compared to ... other medical reasons. Differences in measures of overall ... months after injury are reported in an article ... journal from Mary Ann Liebert, Inc., publishers. The ...
(Date:4/17/2014)... discovering a new mechanism that allows blood to enter ... Irvine and the Salk Institute have opened the door ... brain damage. , A complex and devastating neurological condition, ... reason for disability in the U.S. The blood-brain barrier ... material into the brain, causing the permanent deficits in ...
(Date:4/17/2014)... An international research team led by Cesar A. Arias, ... Center at Houston (UTHealth) has identified a new superbug ... The report appeared in the April 17 issue of ... The new superbug is part of a class of ... or MRSA, which is a major cause of hospital ...
(Date:4/17/2014)... D.C. -- The world is less than 40 years ... implications for people and governments, according to a top ... the first time in human history, food production will ... of land, water and energy," said Dr. Fred Davies, ... security. "Food issues could become as politically destabilizing by ...
(Date:4/17/2014)... lost its status as the leading weapon against the ... life, with new research indicating it simply needs to ... use of the cheap anti-malarial drug chloroquine in treating ... of more than half a million people each year ... has developed resistance to chloroquine, but research carried out ...
Breaking Medicine News(10 mins):Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2Health News:Study IDs new cause of brain bleeding immediately after stroke 2Health News:New MRSA superbug emerges in Brazil 2Health News:Food shortages could be most critical world issue by mid-century 2Health News:Scientists find new way to fight malaria drug resistance 2
... Drug Trend for 2008-- Drug Trend managed to a ... than 40 percent mail order experienced a negative drug ... inflation hit its highest level in five years, but ... growth to 3.3 percent, a new report released by ...
... of hereditary hemochromatosis , is frequently found in ... non-alcoholic fatty liver disease patients . A study ... and steatosis in a non-obese cohort of non-alcoholic ... after exclusion of diagnosis of HH, represent a ...
... (NPR-B) gene was expressed in gastric smooth muscles ... was increased in diabetic rats. These results suggest ... it may contribute to diabetic gastroparesis in STZ-induced ... is frequent in diabetic patients. It is a ...
... Mango, the very popular and fastest-growing retailer of authentic ... "AKA" seal, a certification confirming that Red Mango,s frozen ... high quality, delicious treat by nationally recognized Celebrity Dietitian ... and nutritionist in Los Angeles by Citysearch.com for the ...
... Caron Treatment Centers Poll Examines Challenges , Women ... EmpowermentPHILADELPHIA, May 13 From decreased intimacy ... is having a profound impact on relationships, according to ... Centers , one of the nation,s leading non-profit ...
... CareFusion Corporation, the company that will become public ... medical products businesses, today announced that Edward J. Borkowski ... has been CFO of Mylan, Inc. since 2002 where ... business to one of the largest generic pharmaceutical companies ...
Cached Medicine News:Health News:Mail Service and Higher Generic Use Helps Keep Spending in Check, Countering Brand Drug Price Inflation and Specialty Medication Growth 2Health News:Mail Service and Higher Generic Use Helps Keep Spending in Check, Countering Brand Drug Price Inflation and Specialty Medication Growth 3Health News:Mail Service and Higher Generic Use Helps Keep Spending in Check, Countering Brand Drug Price Inflation and Specialty Medication Growth 4Health News:Mail Service and Higher Generic Use Helps Keep Spending in Check, Countering Brand Drug Price Inflation and Specialty Medication Growth 5Health News:NPs-NPR-B/pGC-cGMP signal pathway is involved in diabetic gastroparesis 2Health News:Red Mango Receives 'AKA' Stamp of Approval From Ashley Koff, R.D., Underscoring Its Commitment to Good Health 2Health News:Red Mango Receives 'AKA' Stamp of Approval From Ashley Koff, R.D., Underscoring Its Commitment to Good Health 3Health News:New Study Shows Stresses of Economic Downturn on Women's Relationships 2Health News:New Study Shows Stresses of Economic Downturn on Women's Relationships 3Health News:New Study Shows Stresses of Economic Downturn on Women's Relationships 4Health News:New Study Shows Stresses of Economic Downturn on Women's Relationships 5Health News:CareFusion Names Edward Borkowski as Chief Financial Officer 2Health News:CareFusion Names Edward Borkowski as Chief Financial Officer 3Health News:CareFusion Names Edward Borkowski as Chief Financial Officer 4
(Date:1/15/2014)... 2014  Manufacturers, suppliers and distributors of innovative medical-related ... their most important business assets, intellectual property (IP). ... Because of the highly-competitive nature of the ... the most litigious industry sectors of cases involving ...
(Date:1/15/2014)... Therapeutics, Inc. (Nasdaq: ECTE ) ("Echo"), a ... a non-invasive, wireless continuous glucose monitoring system, today announced ... Interim CEO of Echo Therapeutics, will present at "TEN", ... Mr. Doman will make a corporate presentation ...
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com ... is available in its catalogue: ... Drug Forecast and Market Analysis to 2022 ... PharmaPoint: Atopic Dermatitis - India Drug Forecast ...
Breaking Medicine Technology:Intellectual Property Insurance for Medical-related Products and Services 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5
... , LAKE FOREST, Ill. , ... and manufacturer of injectable pharmaceuticals, announced today the acquisition ... number of products in development from GeneraMedix Inc. , ... additions to our portfolio, which demonstrates our continuing commitment ...
... , KINGWOOD, Texas , Feb. 12 ... that the company has formally offered to purchase an equity ... in the chronic pain management medical sector. The pharmaceutical company ... identified until IMAI has a signed letter of intent from ...
Cached Medicine Technology:Bioniche Pharma Acquires Seven New Products From GeneraMedix Inc. 2International Merchant Advisors, Inc. Offers to Invest in Pharmaceutical Chain 2
The combination of new measuring principle - Pupil Zone Imaging Method - and unique technology - SLD - offers high accuracy and reliability in refraction measurement....
... Module ACM-8 loads and unloads two centrifuges ... Identification via Cap Recognition the tube type ... in batches of three 5 position racks ... the single centrifuge ACM can be offered ...
... The Recapping System RCS 800 closes various ... efficient and easy way. Different tube heights and ... sealed tubes can be used for send-outs. The ... RSD 800, Aliquoting System RSD 800 and High ...
... detect sequences of the following viruses: ... and 3; influenza virus A and ... and B. Laboratories may use ... *Analyte Specific Reagents. Analytical ...
Medicine Products: